Heart disease patients in the U.S. who need a stent to open clogged arteries but cannot or will not be compliant with the long-term dual anti-platelet therapy (DAPT) required after receiving a drug-eluting stent may soon have an option that is somewhat of a hybrid between a bare-metal and drug-eluting stent. Read More
